Journal of Cardiac Failure
Volume 13, Issue 9 , Pages 738-743 , November 2007

In Patients With Heart Failure Elevated Soluble TNF-Receptor 1 Is Associated With Higher Risk of Depression

  • Alec J. Moorman, MD

      Affiliations

    • Department of Internal Medicine, Division of Cardiology, and Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington
    • ,
  • Dariush Mozaffarian, MD, DrPH

      Affiliations

    • Harvard School of Public Health, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts
    • ,
  • Charles W. Wilkinson, PhD

      Affiliations

    • Geriatric Research, Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, and Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington
    • ,
  • Richard L. Lawler, BS

      Affiliations

    • Gastroenterology/Hepatology Section, Fred Hutchinson Cancer Research Center, Seattle, Washington
    • ,
  • George B. McDonald, MD

      Affiliations

    • Gastroenterology/Hepatology Section, Fred Hutchinson Cancer Research Center, Seattle, Washington
    • ,
  • Barbara A. Crane, RN

      Affiliations

    • Department of Internal Medicine, Division of Cardiology, and Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington
    • ,
  • John A. Spertus, MD, MPH

      Affiliations

    • Mid America Heart Institute and the University of Missouri–Kansas City, Kansas City, Missouri
    • ,
  • Joan E. Russo, PhD

      Affiliations

    • Department of Internal Medicine, Division of Cardiology, and Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington
    • ,
  • April S. Stempien-Otero, MD

      Affiliations

    • Department of Internal Medicine, Division of Cardiology, and Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington
    • ,
  • Mark D. Sullivan, MD, PhD

      Affiliations

    • Department of Internal Medicine, Division of Cardiology, and Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington
    • ,
  • Wayne C. Levy, MD

      Affiliations

    • Department of Internal Medicine, Division of Cardiology, and Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington
    • Corresponding Author InformationReprint requests: Wayne C. Levy, University of Washington, Box 356422, 1959 NE Pacific Street, Seattle, WA 98195.

Received 27 January 2007 ,Revised 13 May 2007 ,Accepted 4 June 2007.

References 

  1. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, et al. Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113:e85–e151
  2. Abramson J, Berger A, Krumholz HM, Vaccarino V. Depression and risk of heart failure among older persons with isolated systolic hypertension. Arch Intern Med. 2001;161:1725–1730
  3. Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med. 2001;161:1849–1856
  4. Sullivan MD, Levy WC, Crane BA, Russo JE, Spertus JA. Usefulness of depression to predict time to combined end point of transplant or death for outpatients with advanced heart failure. Am J Cardiol. 2004;94:1577–1580
  5. Sullivan M, Levy WC, Russo JE, Spertus JA. Depression and health status in patients with advanced heart failure: a prospective study in tertiary care. J Card Fail. 2004;10:390–396
  6. Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res. 2002;91:988–998
  7. Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:201–217
  8. Pasic J, Levy WC, Sullivan MD. Cytokines in depression and heart failure. Psychosom Med. 2003;65:181–193
  9. Ferketich AK, Ferguson JP, Binkley PF. Depressive symptoms and inflammation among heart failure patients. Am Heart J. 2005;150:132–136
  10. Parissis JT, Adamopoulos S, Rigas A, Kostakis G, Karatzas D, Venetsanou K, et al. Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am J Cardiol. 2004;94:1326–1328
  11. Asakuma S, Ohyanagi M, Iwasaki T. Simple methods of assessing physical activity in patients with chronic heart failure. Congest Heart Fail. 2000;6:250–255
  12. Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res. 1992;41:237–248
  13. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000;35:1245–1255
  14. Spitzer RL, Kroenke K, Linzer M, Hahn SR, Williams JB, deGruy FV, et al. Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. JAMA. 1995;274:1511–1517
  15. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62
  16. Mozaffarian D, Rimm EB, King IB, Lawler RL, McDonald GB, Levy WC. Trans fatty acids and systemic inflammation in heart failure. Am J Clin Nutr. 2004;80:1521–1525
  17. Huehnergarth KV, Mozaffarian D, Sullivan MD, Crane BA, Wilkinson CW, Lawler RL, et al. Usefulness of relative lymphocyte count as an independent predictor of death/urgent transplant in heart failure. Am J Cardiol. 2005;95:1492–1495
  18. Diagnostic and statistical manual of mental disorders, ed 4. Washington, DC: American Psychiatric Association; 1994;
  19. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113:1424–1433
  20. Rumsfeld JS, Havranek E, Masoudi FA, Peterson ED, Jones P, Tooley JF, et al. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol. 2003;42:1811–1817
  21. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation. 2001;103:2055–2059
  22. Lee KW, Hill JS, Walley KR, Frohlich JJ. Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort. CMAJ. 2006;174:461–466
  23. Mozaffarian D, Minami E, Letterer RA, Lawler RL, McDonald GB, Levy WC. The effects of atorvastatin (10 mg) on systemic inflammation in heart failure. Am J Cardiol. 2005;96:1699–1704
  24. Young-Xu Y, Chan KA, Liao JK, Ravid S, Blatt CM. Long-term statin use and psychological well-being. J Am Coll Cardiol. 2003;42:690–697
  25. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701–709

 Supported in part by a Charles A. Dana Foundation Grant, Dana Foundation, New York, NY; and in part by an American Heart Association Grant 9970185N to Dr. Sullivan. A portion of this work was conducted through the Clinical Research Center Facility at the University of Washington and supported by Grant M01-RR-00037 from the National Institutes of Health, Bethesda, MD. Dr. McDonald's Cytokine Analysis Laboratory was supported by Grant CA18029 from the National Institutes of Health, Bethesda, MD.

PII: S1071-9164(07)00471-X

doi: 10.1016/j.cardfail.2007.06.301

Journal of Cardiac Failure
Volume 13, Issue 9 , Pages 738-743 , November 2007

Article Tools